Arax Advisory Partners’s Kailera Therapeutics KLRA Stock Holding History
Bought
Maintained
Sold
Other funds holding KLRA
Arax Advisory Partners's KLRA Position: Q3 2026 in Review
Arax Advisory Partners opened a new position in Kailera Therapeutics (KLRA) in Q3 2026: 640 shares worth $7.31K. The stake represents ﹤0.01% of the portfolio and ranks #4545 among its holdings.
132 funds tracked by Wall St. Rank hold KLRA as of Q3 2026.
- Arax Advisory Partners held 640 shares of Kailera Therapeutics worth $7.31K as of Q3 2026.
- Kailera Therapeutics was a new Arax Advisory Partners position in Q3 2026.
- Kailera Therapeutics made up ﹤0.01% of Arax Advisory Partners's portfolio in Q3 2026, its #4545 holding.
- 132 funds tracked by Wall St. Rank held Kailera Therapeutics as of Q3 2026.
Based on Arax Advisory Partners's 13F filing for Q3 2026, filed 12 Nov 2026.